Product information and disease descriptionProduct descriptionProduct information
Co-prescribed/Concomitant therapies
6 evidence topics · 8 sources
Background Huntington's disease medications: stable for 3 months before screening
Excluded prior and concurrent therapies
Immunosuppression regimen specified in the protocols
Immunosuppression at the discretion of the treating physician, October 2022
Perioperative immunosuppression and steroids given with administration, 2023
Prophylactic short-term steroid regimen, May 2025
Agents, doses, and duration of the immunosuppression regimen
No evidence found.